Liver Supplements: Big Sales, Limited Evidence
Researchers evaluate how popular liver cleanse products are formulated and promoted in the US online marketplace.
-
By
-
Kathryn Wighton
-
January 30, 2026
-
Clinical Scorecard: Liver Supplements: Big Sales, Limited Evidence
At a Glance
| Category | Detail |
|---|
| Condition | Liver health and detoxification |
| Key Mechanisms | Detoxification claims primarily based on ingredients with weak or inconclusive clinical support. |
| Target Population | Consumers seeking liver health supplements. |
| Care Setting | Retail and online marketplaces. |
Key Highlights
- Top-selling liver cleanse supplements lack high-quality clinical support.
- Estimated annual sales exceed $38.8 million with over 1.4 million units sold.
- Most products promote detoxification and liver function enhancement.
- Common ingredients include milk thistle, zinc, choline, and berberine.
- 62% of negative reviews cited lack of perceived efficacy.
Guideline-Based Recommendations
Diagnosis
- No specific diagnostic guidelines for liver supplements; focus on clinical evidence.
Management
- Encourage consumers to seek supplements with robust clinical evidence.
Monitoring & Follow-up
- Monitor for gastrointestinal symptoms and other adverse effects.
Risks
- Potential for adverse effects, primarily gastrointestinal symptoms.
Patient & Prescribing Data
General population interested in liver health supplements.
Most ingredients lack strong clinical backing; caution advised.
Clinical Best Practices
- Advise patients to critically evaluate supplement claims.
- Promote supplements with high-quality clinical evidence.
- Encourage reporting of adverse effects from supplement use.
References
